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Periodontal disease is one of the most common infectious diseases of humans. Immune responses to infection trigger loss
of alveolar bone from the jaw and eventual tooth loss. We investigated the contribution of B cell IgD to alveolar bone loss
by comparing the response of B cell normal BALB/cJ mice and IgD deﬁcient BALB/c-Igh-5−/−J mice to oral infection with
Porphyromonasgingivalis,agram-negativeperiodontopathicbacteriumfromhumans.P. gingivalis-infectednormalmicelostbone.
Speciﬁc antibody to P. gingivalis was lower and oral colonization was higher in IgD deﬁcient mice; yet bone loss was completely
absent. Infection increased the proportion of CD69+ activated B cells and CD4+ T cells in immune normal mice compared to IgD
deﬁcient mice. These data suggest that IgD is an important mediator of alveolar bone resorption, possibly through antigen-speciﬁc
coactivation of B cells and CD4+ Tc e l l s .
Copyright © 2009 Pamela J. Baker et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Periodontal diseases are infectious diseases of humans
and other mammals that result in damage to the soft
tissue and periodontal ligaments of the gingiva, resorption
of alveolar bone from the jaw, and, ultimately, loss of
teeth. It is becoming increasingly apparent that there is
extensive interaction and cross-talk between the immune
system and bone remodeling. This new concept has wide-
ranging implications for how we think about the causes
and regulation of bone resorption and has engendered a
new ﬁeld called osteoimmunology [1, 2]. Bone is constantly
remodeling, with osteoblasts building bone and osteoclasts
breaking it down. In a state of health, these two processes
are in balance and the density of bone remains stable.
This balance is disrupted in various diseases, including the
osteoclastic resorptive disease, chronic periodontitis. In this
periodontal disease the progressive loss of alveolar bone is
largelyactivatedbyimmuneresponsestoasmallsubsetofthe
morethan600speciesofbacteriathatcolonizetheoralcavity
[1]. In a murine model that we have developed previously,
we have shown that alveolar bone loss from the jaw can be
triggeredbyoralinfectionwithoneofthese600oralbacterial
species, Porphyromonas gingivalis, a periodontopathic gram-
negative anaerobe from humans [3, 4] .W e ,a n do t h e r s ,h a v e
shown that in response to oral infection B lymphocytes and
CD4+ T lymphocytes of the immune system trigger bone
resorption [1, 3–5].
Despite the prevalence of periodontal disease, the path-
ways to bone loss are not fully understood. In the most
well-characterized pathways, infection upregulates expres-
sion of ligand for receptor activator of NF-κB (RANK-L)
on speciﬁc antigen-activated B and CD4+ Tl y m p h o c y t e s .
These immune cells are then able to bind to RANK on
preosteoclasts, triggering bone resorption [4–7]. We wished
to explore whether there are other immune cell surface
molecules that can induce bone loss. In this study we have
used mice deﬁcient in their B lymphocyte expression of IgD,
a B cell surface immunoglobulin known to be involved in B
cell/T cell cognate activation, but not known to be involved
in bone remodeling.
In immune normal mice and humans, expression of
membrane bound IgD along with IgM indicates that a B
cell has undergone aﬃnity maturation and can begin to2 Interdisciplinary Perspectives on Infectious Diseases
react with speciﬁc antigen and secrete soluble antibody to
that antigen. Igh-5−/− mice have a targeted mutation that
deletes expression of heavy chain-5 (Igh-5), the delta-like
heavy chain of IgD immunoglobulin [8]. Mice deﬁcient in
IgD display a delay in B cell aﬃnity maturation [8]. In
addition, B cell membrane IgD is a ligand for IgD receptors
that are expressed on activated CD4+ T cells [9]. Binding of
IgD to IgD receptors facilitates B cell antigen presentation
to CD4+ T cells by stabilizing T cell receptor binding to the
antigen/MHC complex. This cognate interaction increases
both antibody responses by the B cells and antigen-speciﬁc
clonal expansion of the T cells [9]. We therefore designed
experiments using Igh-5−/− mice to test the hypothesis that
IgD can contribute to alveolar bone loss in response to P.
gingivalis infection.
2.MaterialsandMethods
2.1. Animals. Speciﬁc pathogen-free BALB/c-Igh-5−/−J mice
that are IgD deﬁcient due to a speciﬁc deletion of the Igh
gene [8] and the genetically matched immune normal strain
BALB/cJ were received from The Jackson Laboratory (Bar
Harbor, ME, USA). Mice were kept in the animal colony at
Bates College under conditions described previously [10].
The experimental protocol was reviewed and approved by
the Institutional Animal Care and Use Committee, Bates
College.
2.2. Bacteria. P. gingivalis ATCC 53977 (A7A1-28) was
maintained frozen in deﬁbrinated sheep’s blood at −80
◦C.
For experiments, bacteria were anaerobically grown under
5% CO2, 10% H2 and 85% N2 at 37
◦Cf o r4 – 7d a y s
on supplemented blood agar containing trypticase soy
agar base with 0.1% yeast extract, hemin (5.0μg/mL),
menadione (0.5μg/mL), and 5% deﬁbrinated sheep’s blood.
Bacteria were removed from the plates, gently suspended in
phosphate-buﬀered saline (PBS), and diluted to 1010 colony
forming units (CFU) per mL on the basis of optical density.
Pilot experiments in which serial dilutions of P. gingivalis
wereplatedforcolonycountshadshownthata1:100dilution
of 1010 CFU per mL of P. gingivalis has an optical density of
0.3 at 650nm.
2.3. Oral Infection. Each experiment included ten age-
matchedfemalemice,14to16weeksoldatthestartofexper-
iments.Miceweregivensulfamethoxazole(0.87mg/mL)and
trimethoprim (0.17mg/mL) (Sulfatrim, Goldline Laborato-
ries, Ft. Lauderdale, FL, USA), ad libitum in their drinking
water for 10 days, followed by a 3-day antibiotic-free period.
Mice were then infected by gavage needle and direct oral
exposure three times at 2-day intervals with 109 CFU of
live P. gingivalis in 100μL of PBS with 2% carboxymethyl-
cellulose. Controls received the antibiotic pretreatment and
three sham-infections with carboxymethylcellulose without
P. gingivalis. Forty-two days after the ﬁnal gavage, mice
were euthanized by CO2 [3]. Duplicate experiments yielded
the same results; the results from one experiment are
shown.
2.4. Measurement of Alveolar Bone Loss. Horizontal bone
loss around the maxillary molars of deﬂeshed skulls was
assessed under a dissecting microscope (×40) ﬁtted with a
video image marker measurement system (model VIA 170,
Boeckeler Instruments, Inc., Tucson, AZ, USA) standardized
to give measurements in fractions of mm. The distance from
the cementoenamel junction (CEJ), where the enamel of the
tooth crown meets the cementum of the tooth root, to the
alveolar bone crest of the jaw (ABC) was measured at a total
of 14 buccal sites per mouse (for location of measurement
sites see photographs in [11]). Measurements were done in a
blinded protocol by one investigator.
As alveolar bone resorbs away, additional root cementum
is exposed and the distance from the CEJ to the new location
of the ABC becomes larger. Where the CEJ to ABC is larger
in infected mice than in sham-infected mice, bone loss has
occurred. The CEJ to ABC distance is not zero; consequently,
the CEJ to ABC distance at individual sites in infected mice
was subtracted from the mean of the distance at that site in
sham-infected mice, giving the mm of change in bone at that
site.
2.5. Reisolation of P. gingivalis from the Oral Cavity. At the
time of euthanasia, bacterial samples were collected from the
oral cavity using one sterile paper-point per mouse placed
along the CEJ for 5 seconds on the buccal surface of the
three maxillary molars on the left and 5 seconds along the
molars on the right. Each sample was individually plated and
incubated as described previously [10].
2.6. P. gingivalis-Speciﬁc Antibody. Blood was collected from
each mouse at the time of euthanasia. Sera were stored at
−80
◦C for later assessment of speciﬁc IgM, IgG, and IgA
antibody by enzyme-linked immunosorbent assay (ELISA),
as described previously [10], in polystyrene plates (Costar,
Corning Inc., Corning, NY, USA) coated with formalin-
killed whole P. gingivalis ATCC 53977. The ELISA titer
was deﬁned as the reciprocal of the highest serum dilution
( e x p r e s s e di nl o g 2) that produced absorbance readings more
thantwostandarddeviationsabovebackgroundlevels.TheP.
gingivalis-speciﬁc titer of each infected animal was calculated
by subtraction of the mean value from the sham-infected
animals of that mouse strain.
2.7. Flow Cytometry. Spleens were collected at the time of
euthanasia. Fifty μl of mouse spleen cells at a density of
2×107 cells/mlwerewashedin4mlofwashbuﬀer(0.2gKCl,
8.0gN aCl,1.15gN a 2HPO4,0 . 2gK H 2PO4 and 0.2g NaN3
per liter at pH 7.2) and pelleted at 110×gf o r1 0m i n u t e sa t
15
◦C. The pellets were resuspended in 1ml of the same wash
buﬀer and were blocked with 10μlo fn o r m a lr a tI g G( S i g m a
Chemical Company, St. Louis, MO, USA) and incubated for
15 minutes at 7◦C. Cells were immunostained for 30 minutes
at 7◦C with either 10ul of prediluted hamster antimouse
CD69 conjugated to FITC to show activation status, or
phycoerythrin-conjugatedhamsterantimouseCD19tomark
B cells or hamster anti-mouse CD4 to mark CD4+ T cells,
and FITC- or phycoerythrin-labeled hamster IgG as isotypeInterdisciplinary Perspectives on Infectious Diseases 3
controls (The Jackson Laboratory, Bar Harbor, ME, USA).
Unadsorbed antibody was removed by adding wash buﬀer
and centrifuging at 60×gf o r1 0m i n u t e sa t1 0
◦C. Cells were
resuspended in 0.5ml ﬂow cytometry buﬀer(thewashbuﬀer
with 5ml/l fetal bovine serum added). Five μl of propidium
iodide at 20μg/ml were added to determine cell viability.
Data were acquired on a FACSORT (Becton-Dickinson,
San Jose, CA, USA) and were analyzed using CellQuest.
Lymphocytes were gated on the basis of forward scatter and
side scatter of incident light [12].
2.8. Statistics. Diﬀerences between the infected and sham
groups and between infected mice of diﬀerent strains were
evaluated by two-tailed, unpaired t-tests (Excel; Microsoft,
Redmond, WA, USA).
3. Results
TheeﬀectsoforalinfectionwithP. gingivalis onalveolarbone
are shown in Figure 1. In BALB/cJ mice with normal IgD
levels the CEJ to ABC distance was larger in infected mice
than in sham-infected mice at each of the 14 measurement
sites, indicating that the infected BALB/cJ mice had lost bone
at every site (Figure 1(a)). In contrast, in IgD deﬁcient mice
the CEJ to ABC distances were the same in infected mice as
in sham-infected mice, showing that without B cell IgD mice
did not lose bone at any site (Figure 1(b)).
Summing the amount of bone change at all 14 sites addi-
tionally demonstrated that bone loss occurred in immune
normal mice but not in IgD deﬁcient mice. The summed
changeininfectedBcellnormalBALB/cJmicewasameanof
−0.302 ± 0.035mm of bone. In contrast, the summed bone
change in infected IgD deﬁcient mice was 0.040 ± 0.024mm
(P = 1.28 ×10
−7).
To be sure that lack of bone loss could not be explained
by a lack of infection, we reisolated P. gingivalis from the oral
cavitiesbypaperpoint.P. gingivalis waspresentineachofthe
infected mice of both strains and was not present in any of
the uninfected mice (data not shown). The P. gingivalis load
was actually much higher (a mean of 100 ± 10 colonies per
plate, n = 10) in the IgD deﬁcient mice than in the immune
normal mice where the mean was only 2 ± 1 colonies per
plate (data not shown).
The diﬀerence in bacterial load may reﬂect diﬀerences
between the mouse strains in their production of P. gingi-
valis-speciﬁc serum antibody. After infection, both mouse
strains produced a speciﬁc antibody response signiﬁcantly
higher(P<. 05)thanthebackgroundlevelsinsham-infected
animals (data not shown); however, the titers of each of the
three antibody isotypes in the infected mice were lower in
the IgD deﬁcient mice than in the immune normal mice
(P<. 05) (Figure 2).
Despite the diﬀerences in serum antibody titers, Igh-
5−/− mice are known to have normal proportions of B
cells [8]. This was conﬁrmed in our experiments by ﬂow
cytometry measurements on the day of euthanasia, 42
days postinfection by comparing the sham-infected mice
of the two strains. The mean percentage of B cells was
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Figure 1: Changes in bone levels due to oral infection with P.
gingivalis. The distance from the CEJ on the tooth to the ABC of
the jaw was measured at 14 buccal sites on the maxillary molars,
seven sites on the left (L) and seven on the right (R), with site
number 1 located closest to the midline. Each point indicates the
mean measurement at that site ±1S E M( n = 10 mice). (a)
Immune normal BALB/cJ mice showed alveolar bone resorption
when infected with P. gingivalis. The distances from the CEJ to the
ABCweresigniﬁcantlylargerininfectedmicethaninsham-infected
mice (P<. 05) at each of the 14 sites, indicating that alveolar bone
resorbed at every measurement site. (b) IgD deﬁcient IgH5−/− mice
did not show alveolar bone resorption. The distances from the CEJ
t ot h eA B Cw e r et h es a m ei nP. gingivalis-infected mice as in sham-
infected mice (P>. 05).
higher in IgD knockout mice than in normal mice, but the
diﬀerencebetweenthetwomousestrainswasnotstatistically
signiﬁcant (Figure 3(a)). In neither mouse strain did P.
gingivalis-infection change the percentage of total B cells
compared with sham-infected mice (Figure 3(a)). Although
total B cell percentages were unchanged, a higher percentage
of B cells were activated in infected BALB/cJ mice than in
infected IgD knockout mice (P<. 05; Figure 3(b)).
WealsoexaminedtheCD4+ Tcellpopulationsinthetwo
mouse strains. In BALB/cJ mice P. gingivalis-infection led to
a signiﬁcant increase in the mean percentage of total viable
CD4+ T cells compared with sham-infected BALB/cJ mice
(P<. 05). In IgD deﬁcient mice, however, infection did not4 Interdisciplinary Perspectives on Infectious Diseases
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Figure 2: P. gingivalis-speciﬁc serum antibody titers of all three
isotypes were signiﬁcantly lower in infected IgD deﬁcient mice
compared with immune normal BALB/cJ mice (P<. 05). Bars
represent the mean anti-P. gingivalis titer of infected mice ± SEM
(n = 10)aftersubtractionofthemeanvalueforsham-infectedmice
of the same strain.
increase the CD4+ Tc e l lp o p u l a t i o n( Figure 4(a)). Similarly,
infection activated CD4+ T cells in BALB/cJ mice, as shown
bytheincreasedpercentageofCD69+ CD4+ Tcells,butitdid
not activate T cells in IgD deﬁcient mice (Figure 4(b)).
4. Discussion
In this study, we show that mice with B cells lacking surface
IgD do not experience alveolar bone loss after oral infection
with P. gingivalis (Figure 1). One possible explanation for
the lack of bone loss could be that the mice were colonized
by with a diminished load of P. gingivalis. Reisolation of
the bacteria eliminated this possibility; IgD deﬁcient mice
actually harbored higher numbers of this bacterium than
immunenormalmice.Highercolonizationmaybeduetothe
lower antibody titers found in the IgD deﬁcient (Figure 2).
These reduced titers are in line with earlier studies showing
that diminished antibody response is due to the delayed
aﬃnity maturation characteristic of this IgD mutation [8].
Previous studies in immune normal mice have demonstrated
that antibody may decrease bacterial load but antibody is not
protectiveagainstboneloss:lowerantibodytitersdonotlead
to more bone loss [13].
We cannot entirely exclude another possibility; that is,
that the resistance to bone loss seen in the IgD deﬁcient
mice was due to residual contamination with alleles from
the 129 or C57BL/6 progenitor strains. The Igh knockout
was originally generated on the C57BL/6 genetic background
by gene targeting with an embryonic stem cell line derived
from murine strain 129 [8]. BALB/c-Igh-5−/−J mice were
produced by backcross onto the BALB/cJ strain for seven
generations.StrainBALB/cJisgeneticallysusceptibletobone
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Figure 3: Pg i n g i v a l i s - infected IgD deﬁcient mice had a lower
proportion of activated B cells than infected immune normal
BALB/cJ mice. (a) The total B cell population: the percentage of
total viable CD19+ B cells in the sham-infected mice were the same
in both strains (P>. 05). In neither mouse strain was the total B
cell population changed by P. gingivalis infection (P>. 05, infected
compared to sham-infected mice). (b) Activated B cell population:
the proportion of activated B cells in infected IgD deﬁcient mice
were signiﬁcantly lower than in infected BALB/cJ mice, (P<. 05,
indicated by ∗) n = 8; 42 days postinfection.
loss after oral infection with P. gingivalis, while strains 129
and C57BL/6 show moderate resistance to bone loss in
some experiments [11]; however, mice within each cohort
do lose bone after infection. In seven backcross generations
the progenitor genotypes are predicted to be diluted 1 in
27, leaving less than 0.8% of the progenitor alleles carried
into the BALB/cJ genome and then only if they are closely
linked to the target Igh gene. In the experiments presented in
this paper, no infected BALB/c-Igh-5−/−J mouse showed an
increase in the CEJ to ABC distance (our measure of bone
loss) that was beyond one standard error of the mean valueInterdisciplinary Perspectives on Infectious Diseases 5
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Figure 4: P. gingivalis-infection increased the proportion of CD4+ T cells and activated them in immune normal BALB/cJ mice but not in
IgDdeﬁcientmice.(a)TotalCD4+ Tcellpopulation:inimmunenormalBALB/cJmicethepercentageoftotalviableCD4+ Tcellswerehigher
in infected than in sham-infected (P<. 05) but in IgD deﬁcient mice the percentage was unchanged by infection (P>. 05). (b) Activated
CD4+ T cells: In BALB/cJ mice the proportion of activated CD4+ CD69+ T cells were higher in P. gingivalis-infected than in sham-infected
mice (P<. 05) but activation was not increased by infection in IgD deﬁcient mice (P>. 05). n = 10.
of the shams; that is, the distance from the CEJ to the ABC
in every infected mouse was within the range of variation
of the sham mice. We therefore think it highly unlikely that
the absence of bone loss observed in the infected mice is the
result of passenger 129 or C57BL/6 gene loci but is instead an
intrinsic feature of the Igh deﬁciency.
We propose that the resistance to bone loss is due to
the inability of IgD deﬁcient B cells to act as costimulators
of antigen-speciﬁc T cells. T lymphocytes and other cells
are normal in Igh-5−/− mice [8]. T cells have IgD receptors
that are lectins and bind to O-glycans on B cell surface IgD
immunoglobulin [14]. These IgD receptors are present on
very low numbers of peripheral T cells but are moved to the
surface membrane in response to activation by antigen [9].
The upregulated IgD receptor on an antigen-speciﬁc T cell
binds to IgD on a B cell bearing the same antigen, stabilizing
theTcellreceptor/MHCIIconnectionbetweenthetwotypes
of lymphocytes, facilitating activation of both.
Other forms of costimulation have been shown to be
important in alveolar bone loss. Inﬂammatory bone resorp-
tion triggered by Aggregatibacter (formerly Actinobacillus)
actinomycetemcomitans requires activation of Th1 CD4+ T
cells, and this activation requires costimulation of B7 on the
T cell surface. Blocking of B7 abrogated costimulation and
inhibited bone resorption in a rat model [15]. The present
results suggest that B cell IgD binding to CD4+ Tc e l lI g D
receptors is a pathway to costimulation of both B cells and
CD4+ Tc e l l si nP. gingivalis-induced disease. Our experi-
ments show that oral infection of immune normal mice with
P. gingivalis leads to both serum antibody response (Figure 2,
anindication ofBcellactivation) andtohighernumbersand
activation of CD4+ T cells (Figure 4). In contrast, Igh-5−/−
mice lacking IgD showed signs of less activation of both B
and T cells. They produced lower antibody titers (Figure 2),
h a df e w e ra c t i v a t e dBc e l l s( Figure 3), and did not show an
increase in T cell population or activation at 42 days after
infection (Figure 4).
The mechanism by which this cognate B and T cell
activation stimulates bone loss is not known at this time.
It is not likely to be due to the eﬀect of IgD deletion on
antibodysecretion,asantibodyisnotprotectiveagainstbone
loss [13]. One well-studied immunological pathway to bone
loss is upregulation of RANK-L on activated lymphocytes.
Both B cells and T cells express membrane bound and
soluble RANK-L after activation [16, 17], and bone loss
can be triggered by the binding of this ligand to RANK on
preosteoclasts. However, both CD4+ and CD8+ T cells can
express RANK-L after activation [16]. We have shown that
CD4+ T cells and their cytokines are involved in alveolar
bone loss in mice, but that CD8+ T cells are not [3].
OthershavealsoimplicatedCD4+ cells[2,15,18],suggesting
that there may a pathway in addition to RANK-L that is
particular to CD4+ but not CD8+ T cells. Although we have
some preliminary data showing that the proportion of CD4+
spleen cells expressing membrane surface RANK-L was the
same in infected immune normal mice that lost bone as it
was in IgD deﬁcient mice that did not lose bone (data not
shown), we have not examined RANK-L expression on T or
B cells in the gingiva.
One pathway that could distinguish between CD4+ and
CD8+ T cells is the pathway suggested by these experiments,
that is, activation through the T cell IgD receptor. In mice,
only CD4+ T cells express IgD receptors and so CD8+ T
cells cannot participate in the costimulation [9]. CD4+ T
cell/ B cell interaction may provide suﬃcientampliﬁcationof
RANK-L upregulation that the cells triggering osteoclasts are
largely restricted to B cells and CD4+ T cells. Han et al. have
shown that adoptive transfer of antigen-responsive B cells6 Interdisciplinary Perspectives on Infectious Diseases
can induce bone loss in rats that are congenitally athymic
and therefore T cell deﬁcient [19]. It is possible that B
cells are alone responsible for the eﬀects on bone loss seen
in these experiments, but the activation of CD4+ Tc e l l s
over an extended period of time (42 days postinfection;
Figure 4) would argue that T cell activation is playing at
least an amplifying role, either through RANK-L or through
increased secretion of bone resorptive cytokines [3, 20].
5. Conclusion
Genetic deletion of IgD was shown here to diminish T and B
cell activation and to inhibit alveolar bone loss in mice. This
study suggests a new pathway through which oral infection
with P. gingivalis can result in loss of alveolar bone. In
response to oral infection, IgD on the surface of B cells binds
to IgD receptors on CD4+ T cells, resulting in coactivation of
both B and T cells of the immune system. Such B and T cell
activation can, in turn, activate osteoclasts and trigger bone
loss.Chronicperiodontitisisawidespreadinfectiousdisease;
therefore, elucidation of the mechanisms through which the
immune responses to infection trigger damage rather than
protection is of clinical importance.
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